Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...
This paper introduces a non-isolated DC–DC boost converter specifically designed for renewable-energy applications, emphasizing low input-current ripple and a reduced number of components. The ...
G-Shock’s new watch may revisit its oldest design from the 1980s. But the technique used for its unique bezel and bracelet actually dates back more than a millennium. Tsuiki, believed to have ...
Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...
This paper presents a modified hybrid DC-DC boost converter topology with enhanced voltage gain capability for renewable energy applications, particularly suited for photovoltaic and micro-hydro power ...
An expert explains how the new program, which launches July 1, will work and who is eligible Key Takeaways A new Medicare pilot program will offer GLP-1 weight-loss medications for $50 a month ...
Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. While providers may prescribe this drug off label ...
Advanced HDR by Technicolor said June 2 it has joined the Pearl TV NextGen TV Converter Box Program, an initiative to support development of affordable ATSC 3.0 converter boxes for the U.S. market.
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Gastrointestinal and ...
The Center for Healthy Living (CHL) launched a new, free weight management program in 2025. This free program is designed to provide benefits-eligible employees and covered dependents with an ...
Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...